We’re excited to show our customers the width and breadth of our DrugDev Spark clinical operations suite, which now includes the first SaaS solution that gives sponsors and CROs the freedom to design and deploy patient consent systems quickly and effectively in-house.
PHILADELPHIA and LONDON (PRWEB)
February 08, 2018
Once again DrugDev and its customers are gearing up to transform clinical operations through industry collaboration, standardization and a beautiful technology experience at the CHI SCOPE Summit for Clinical Operations Executives at the Hyatt Regency Orlando, February 12-15.
Visitors to DrugDev ‘s Booth #400 will get the world’s first look at Consent Engineering, an exciting new SaaS solution on the DrugDev Spark™ clinical operations suite. More details will be unveiled at SCOPE, including at a luncheon presentation (see below). Additional demos available at the booth include industry-leading technology solutions for site selection and activation, site payments, LMS and site engagement, document management, and safety notifications. Click here to schedule a hands-on demonstration of technology to transform your clinical trials.
During the session, DrugDev executives, customers and subject matter experts will contribute to the conversation by hosting and presenting SCOPE Summit keynotes, sessions and roundtables:
Monday, February 12
- (5:00pm) Keynote: “Where Are Clinical Trials Headed for 2018?” Ibs Mahmood, DrugDev President and CEO will join an expert panel including Christopher Rull, Principle Consultant, CR Consulting, LLC, former Vice President, Head of Business Development & Account Management, UBC; Joan Shaw, Vice President, Global Clinical Development & Operations, UBC; Greg Skalicky, Chief Enterprise Business Officer, Syneos Health; Jeffrey…